See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no inherent risk in receiving the flu vaccine before taking Cosentyx (secukinumab) [1]. Cosentyx is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. It is a type of drug called a monoclonal antibody, which works by targeting a specific molecule in the body called interleukin-17A (IL-17A) [2].

The Centers for Disease Control and Prevention (CDC) recommends that everyone six months of age and older get a flu vaccine every year [3]. The flu vaccine is typically given in the fall or winter, and it is important to get vaccinated before the flu starts spreading in your community [3].

There is no evidence to suggest that receiving the flu vaccine before taking Cosentyx increases the risk of adverse events or reduces the efficacy of the vaccine [1]. However, it is always a good idea to consult with a healthcare provider before receiving any vaccinations or starting a new medication [1].

In summary, based on the available information, there are no known risks associated with receiving the flu vaccine before taking Cosentyx. It is important to consult with a healthcare provider before receiving any vaccinations or starting a new medication.

Sources:

1. DrugPatentWatch.com. (n.d.). Cosentyx (secukinumab) - DrugPatentWatch. Retrieved from <https://www.drugpatentwatch.com/drugs/cosentyx>
2. Novartis. (2021). Cosentyx (secukinumab). Retrieved from <https://www.cosentyx.com/about-cosentyx/what-is-cosentyx>
3. Centers for Disease Control and Prevention. (2021). Who Needs a Flu Vaccine and When. Retrieved from <https://www.cdc.gov/flu/season/faq-influenza.htm#who-and-when>